Recall Monitor
Health Products

Apo-Semaglutide Injection : Incorrect dose display

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: Apo-Semaglutide Injection
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Distribution: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Ontario, Quebec
Audience: General public, Healthcare, Industry
Recall class: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandProduct NameMarket AuthorizationDosage FormStrengthLot Number
Apotex Inc.Apo-Semaglutide (4mg/pen)DIN 02568012Solution1.34 mg/mL7000636A

Issue

The affected lot may display a dose of 0.25 mg or 0.5 mg in the dose window and deliver one of these doses instead of the expected 1 mg dose.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime